LO5 : Sofosbuvir + peginterferon/ribavirin for 12 weeks vs sofosbuvir + ribavirin for 16 or 24 weeks in genotype 3 HCV infected patients and treatment-experienced cirrhotic patients with genotype 2 HCV: The boson study
JOURNAL OF HEPATOLOGY（2015）
关键词
hcv,sofosbuvir,cirrhotic patients,peginterferon/ribavirin,infected patients,treatment-experienced
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要